Recommended Conferences

Fungal Infections and Treatments

Miami, USA

Clinical Microbiology and Infectious Diseases

Miami, USA

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

Economic Burden of Psoriasis in the United States

Author(s): Brezinski EA, Dhillon JS, Armstrong AW

Abstract

Importance  The total cost of psoriasis in the United States is unknown. Defining the US economic burden of psoriasis is needed because it provides the foundation for research, advocacy, and educational efforts.

Objective  To determine the US economic burden of psoriasis from a societal perspective.

Evidence Review  PubMed and MEDLINE databases were searched between January 1, 2008, and September 20, 2013, for economic investigations on the direct, indirect, intangible, and comorbidity costs of adult psoriasis in the United States. The base year costs were adjusted to 2013 US dollars using the Consumer Price Index for All Urban Consumers and multiplied by the estimated number of US patients with psoriasis in 2013 to determine the 2013 psoriasis cost burden.

Findings  Among 100 identified articles, 22 studies were included in the systematic review. The direct psoriasis costs ranged from $51.7 billion to $63.2 billion, the indirect costs ranged from $23.9 billion to $35.4 billion, and medical comorbidities were estimated to contribute $36.4 billion annually in 2013 US dollars. Patients with psoriasis would pay a lifetime cost of $11 498 for relief of physical symptoms and emotional health; however, intangible cost data are limited. The annual US cost of psoriasis amounted to approximately $112 billion in 2013.

Conclusions and Relevance  The economic burden of psoriasis is substantial and significant in the United States.

Similar Articles

The burden of skin diseases

Author(s): Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, et al.

The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions

Author(s): Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP et al.

Economic Burden of Psoriasis in the United States

Author(s): Brezinski EA, Dhillon JS, Armstrong AW

Maintaining skin integrity in the aged: A systematic review

Author(s): Kottner J, Lichterfeld A, Blume-Peytavi U

Adalimumab regulates intracellular TNFa production in patients with rheumatoid arthritis

Author(s): Zamora-Atenza C, Diaz-Torne C, Geli C, Diaz-Lopez C, Ortiz MA, et al.

Nuclear receptors and lipid physiology: opening the X-files

Author(s): Chawla A, Repa R, Evans M, Mangelsord DJ

The pleiotropic actions of vitamin D

Author(s): Lin R, White JH

Vitamin D and the anti-viral state

Author(s): Jeremy A. Beard A, Striker A

Therapeutic implications of the TLR and VDR partnership

Author(s): Liu PT, Krutzik SR, Modlin RL

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D dependent mechanism

Author(s): Robert SJA, Dorschner, Coda AB, Büchau AS, Liu PT, et al.

2016

Author(s): Arantes EL, Dragano N, Ramalho A, Vitorino D, de-Souza GF, et al

A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice

Author(s): Da Young Oh, Walenta E, Akiyama TE, Lagakos WS, Lackey D, et al.

Vitamin D receptor is essential for normal keratinocyte stem cell function

Author(s): Cianferotti L, Cox M, Skorija K, Demay MB

UV photoprotection by combination topical antioxidants vitamin C and vitamin E

Author(s): Lin JY, Selim MA, Shea CR, Grichnik JM, Omar MM, et al.

CAM use in dermatology

Author(s): Barbosa NS, Kalaaji AN

The role of vitamin C in pushing back the boundaries of skin aging: an ultrasonographic approach

Author(s): Crisan D, Roman I, Crisan M, Scharffetter-Kochanek K, Badea R

MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search

Author(s): Noa Rappaport, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, et al.

The burden of skin diseases

Author(s): Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, et al.

The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions

Author(s): Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP et al.

Maintaining skin integrity in the aged: A systematic review

Author(s): Kottner J, Lichterfeld A, Blume-Peytavi U

Adalimumab regulates intracellular TNFa production in patients with rheumatoid arthritis

Author(s): Zamora-Atenza C, Diaz-Torne C, Geli C, Diaz-Lopez C, Ortiz MA, et al.

Nuclear receptors and lipid physiology: opening the X-files

Author(s): Chawla A, Repa R, Evans M, Mangelsord DJ

The pleiotropic actions of vitamin D

Author(s): Lin R, White JH

Vitamin D and the anti-viral state

Author(s): Jeremy A. Beard A, Striker A

Therapeutic implications of the TLR and VDR partnership

Author(s): Liu PT, Krutzik SR, Modlin RL

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D dependent mechanism

Author(s): Robert SJA, Dorschner, Coda AB, Büchau AS, Liu PT, et al.

2016

Author(s): Arantes EL, Dragano N, Ramalho A, Vitorino D, de-Souza GF, et al

A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice

Author(s): Da Young Oh, Walenta E, Akiyama TE, Lagakos WS, Lackey D, et al.

Vitamin D receptor is essential for normal keratinocyte stem cell function

Author(s): Cianferotti L, Cox M, Skorija K, Demay MB

UV photoprotection by combination topical antioxidants vitamin C and vitamin E

Author(s): Lin JY, Selim MA, Shea CR, Grichnik JM, Omar MM, et al.

CAM use in dermatology

Author(s): Barbosa NS, Kalaaji AN

The role of vitamin C in pushing back the boundaries of skin aging: an ultrasonographic approach

Author(s): Crisan D, Roman I, Crisan M, Scharffetter-Kochanek K, Badea R